Catalyst Wire Dossier Catalyst Wire Dossier

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Influenza vaccine, inactivated, quadrivalent (split virion) · Sinovac Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, covering 2024-05-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women [Phase 3]

See pricing